On 1/2/24, MiMedx Group Inc (NASDAQ: MDXG) stock suffered a major decline of -10.3%, closing at $7.87. Moreover, trading volume in this decline was exceptionally high at 227% of normal. The stock has declined -12.4% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, MDXG is expected to be a major Value Eraser.
MiMedx Group is currently unrated.
Rating Review
The stock is currently unrated.